Table 2 Subgroup analysis of CD64 in the diagnosis of sepsis

overall

19

0.89 [0.82, 0.93]

0.88 [0.84,0.92]

59 [30, 115]

0.94 [0.91,0.96]

90.39

76.03

 size≥100

8

0.82 [0.71,0.89]

0.87 [0.81,0.91]

29 [13,64]

0.91 [0.88,0.93]

91.53

78.72

 size< 100

11

0.92 [0.86,0.96]

0.90 [0.84,0.94]

105 [44,252]

0.95 [0.93,0.97]

62.09

13.49

 China

6

0.89 [0.84, 0.93]

0.86 [0.80,0.91]

53 [30, 92]

0.92 [0.89, 0.94]

49.79

0.00

 non-China

13

0.88 [0.79, 0.94]

0.89 [0.84,0.93]

64 [24, 168]

0.94 [0.92, 0.96]

92.42

83.07

 ICU

13

0.89 [0.80, 0.94]

0.90 [0.86,0.93]

73 [29, 183]

0.94 [0.92, 0.96]

93.18

78.96

 non-ICU

4

–

–

–

–

–

–

 FMC

16

0.87 [0.82, 0.91]

0.88 [0.83,0.91]

50 [27, 96]

0.94 [0.91, 0.96]

86.71

71.13

 Leuko64 kit

3

–

–

–

–

–

–

 age ≥ 65 y

2

–

–

–

–

–

–

 age < 65 y

11

0.89 [0.81, 0.94]

0.90 [0.86,0.93]

77 [37, 164]

0.94 [0.91, 0.96]

90.02

61.12